PROFILE OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN PATIENTS WITH BLOOD DISORDERS

被引：0

作者：

Zuk-Wasek, Anna ^{[1
]}

Litwinska, Bogumila ^{[1
]}

Traczyk, Zdzislawa ^{[2
]}

机构：

[1] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Virol, PL-00791 Warsaw, Poland

[2] Inst Haematol & Transfusiol, Dept Internal Dis, PL-02776 Warsaw, Poland

来源：

BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY | 2008年 / 52卷 / 04期

关键词：

humans; Epstein-Barr virus; antibodies; blood disorders;

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

The aim of the study was to investigate the profile of Epstein-Barr virus (EBV) antibodies and to compare this profile with the detectability of EBV DNA and compare this profile in healthy people with the profile in patients with blood disorders. The profile of antibodies was examined in serum from the following groups: 40 patients with blood disorders, but without EBV DNA in their lymphocytes, 44 patients with blood disorders and EBV DNA in lymphocytes, and 46 healthy people. EBV antibodies were detected by using ELISA commercial kits. The obtained results were analysed by Fisher's exact test. No significant differences in antibody profiles were found between EBV DNA-positive and EBV DNA-negative sera. Between patients and the control group, considerable differences were observed in reactivation and in past infection, and a significant difference was observed in chronic infection. These analyses suggest that EBV reactivation or chronic infection can be related with blood disorders and have an influence on the course of blood disorders.

引用

页码：507 / 510

页数：4

共 50 条

[41] Epstein-Barr virus microRNAs and lung cancer
Koshiol, J.
Gulley, M. L.
Zhao, Y.
Rubagotti, M.
Marincola, F. M.
Rotunno, M.
Tang, W.
Bergen, A. W.
Bertazzi, P. A.
Roy, D.
Pesatori, A. C.
Linnoila, I.
Dittmer, D.
Goldstein, A. M.
Caporaso, N. E.
McShane, L. M.
Wang, E.
Landi, M. T.
BRITISH JOURNAL OF CANCER, 2011, 105 (02) : 320 - 326
[42] Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders
Khedmat, Hossein
Alavian, Seyed Moayed
Taheri, Saeed
ANNALS OF TRANSPLANTATION, 2010, 15 (02) : 40 - 44
[43] Epstein-Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders
Cossu, Davide
Tomizawa, Yuji
Sechi, Leonardo Antonio
Hattori, Nobutaka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
[44] Treatment of Epstein-Barr Virus infection in immunocompromised patients
Pociupany, Martyna
Snoeck, Robert
Dierickx, Daan
Andrei, Graciela
BIOCHEMICAL PHARMACOLOGY, 2024, 225
[45] The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment
Pham, H. Phuong T.
Saroukhani, Sepideh
Lindsey, J. William
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
[46] Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, Gunnar
Trier, Nicole Hartwig
FRONTIERS IN IMMUNOLOGY, 2021, 11
[47] Immuno-PCR Assay for Quantitation of Antibodies to Epstein-Barr Virus
Pivovarov, V. D.
Ryazantsev, D. Yu.
Simonova, M. A.
Yegorova, T. V.
Khlgatian, S. V.
Zavriev, S. K.
Svirshchevskaya, E. V.
MOLECULAR BIOLOGY, 2018, 52 (04) : 629 - 635
[48] Serostatus of Epstein-Barr virus in Iranian MS patients
Karampoor, Sajad
Zahednasab, Hamid
Pirkouh, Angila Ataei
Monavari, Seyed Hamid Reza
Ramagopalan, Sreeram
Keyvani, Hossein
ACTA NEUROLOGICA BELGICA, 2016, 116 (01) : 43 - 46
[49] Evaluation of dried blood spots for Epstein-Barr virus nucleic acid testing
Peng, Mei
Li, Hui -Lan
Zhai, Aixia
Zhu, Qian-Ying
JOURNAL OF CLINICAL VIROLOGY, 2024, 174
[50] Characterization of monoclonal antibodies to the Zta and DNase proteins of Epstein-Barr virus
Tsai, CH
Liu, MT
Chen, MR
Lu, J
Yang, HL
Chen, JY
Yang, CS
JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (2-3) : 69 - 77

← 1 2 3 4 5 →